MIRA INFORM REPORT
|
Report No. : |
312483.2 |
|
Report Date : |
04.05.2015 |
IDENTIFICATION DETAILS
|
Name : |
NARANG BIOTEC PRIVATE LIMITED |
|
|
|
|
Registered
Office : |
6943/2, Jaipuria Building, Kolhapur Road, Kamla Nagar, Delhi – 110007 |
|
Tel. No.: |
91-11-32320921 |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as
on) : |
31.03.2015 (Provisional) |
|
|
|
|
Date of
Incorporation : |
30.03.2012 |
|
|
|
|
Com. Reg. No.: |
55-233785 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
Rs. 2.500 Million |
|
|
|
|
CIN No.: [Company Identification
No.] |
U24100DL2012PTC233785 |
|
|
|
|
IEC No.: |
Not Available |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
DELN13389F |
|
|
|
|
PAN No.: [Permanent Account No.] |
AADCN9531B |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business
: |
Trader of Medicines and Pharma Products. |
|
|
|
|
No. of Employees
: |
15 (Approximately) |
RATING & COMMENTS
|
MIRA’s Rating : |
B (27) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Status : |
Moderate |
|
|
|
|
Payment Behaviour : |
Slow but correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is an established company having moderate track record. For the financial year 2014, sales turnover of the company has
increased over previous and company has achieved nearly 78% topline growth. Even though company has shown decent topline growth but it fails to
maintain profitability margins and profitability stood at 0.049%. Further
reserve of the company is low and due to which net worth position of the
company is weak. However, trade relations are reported fair. Payments are reported to
be slow but correct. In view of moderate financial profile, the company can be considered
for business dealing with some caution. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – December 31, 2014
|
Country Name |
Previous Rating (30.09.2014) |
Current Rating (31.12.2014) |
|
India |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
EXTERNAL AGENCY RATING
NOT AVAILABLE
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter in
the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2014.
INFORMATION PARTED BY
|
Name : |
Mr. Rakesh Narang |
|
Designation : |
Director |
|
Contact No.: |
91-9810014268 |
|
Date : |
24.04.2015 |
LOCATIONS
|
Registered/ Head Office : |
6943/2, Jaipuria Building, Kolhapur Road, Kamla Nagar, Delhi – 110007,
India |
|
Tel. No.: |
91-11-32320921/ 23859003/ 4 |
|
Mobile No.: |
91-9810014268 (Mr. Rakesh Narang) |
|
Fax No.: |
Not Available |
|
E-Mail : |
|
|
Area : |
1000 Sq. ft. |
|
Location : |
Owned |
DIRECTORS
AS ON 30.09.2014
|
Name : |
Mr. Rakesh Narang |
|
Designation : |
Director |
|
Address : |
14-35, Shakti Nagar, Delhi – 110007, India |
|
Date of Birth/Age : |
13.01.1960 |
|
Date of Appointment : |
30.03.2012 |
|
PAN No.: |
AADPN0116B |
|
DIN No.: |
05228365
|
|
|
|
|
Name : |
Mr. Anuj Narang |
|
Designation : |
Director |
|
Address : |
14-35, Shakti Nagar, Delhi – 110007, India |
|
Date of Birth/Age : |
21.04.1991 |
|
Date of Appointment : |
30.03.2012 |
|
PAN No.: |
AJBPN3463C |
|
DIN No.: |
05228373
|
|
|
|
|
Name : |
Mr. Sushma Narang |
|
Designation : |
Director |
|
Address : |
14-35, Shakti Nagar, Delhi – 110007, India |
|
Date of Birth/Age : |
10.08.1960 |
|
Date of Appointment : |
21.05.2012 |
|
PAN No.: |
AADPN0142R |
|
DIN No.: |
05285768
|
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
AS ON 30.09.2014
|
Names of Shareholders |
No. of Shares |
Percentage of
Holding |
|
Rakesh Narang |
180000 |
72.00 |
|
Anuj Narang |
50000 |
20.00 |
|
Sushma Narang |
20000 |
8.00 |
|
|
|
|
|
Total |
250000 |
100.00 |
%2004-May-2015_files/image009.gif)
AS ON 30.09.2014
|
Equity Share Breakup |
Percentage of Holding |
|
Category |
|
|
Directors
or relatives of directors |
100.00 |
|
|
|
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Trader of Medicines and Pharma Products. |
|
|
|
|
Brand Names : |
-- |
|
|
|
|
Agencies Held : |
-- |
|
|
|
|
Exports : |
|
|
Products : |
-- |
|
Countries : |
-- |
|
|
|
|
Imports : |
|
|
Products : |
-- |
|
Countries : |
-- |
|
|
|
|
Terms : |
|
|
Selling : |
Cash and Credit |
|
|
|
|
Purchasing : |
Cash and Credit |
PRODUCTION STATUS: NOT AVAILABLE
GENERAL INFORMATION
|
Suppliers : |
· Concept Pharmaceuticals Limited Mumbai, Maharashtra, India |
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Customers : |
· Helpline Pharmacy New Delhi, India |
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
No. of Employees : |
15 (Approximately) |
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Bankers : |
|
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Facilities : |
(RS. IN MILLION)
|
|
|
|
|
Auditors : |
|
|
Name : |
H L Bansal and Company Chartered Accountants |
|
Address : |
23/4, Chadha Bahwan, Shakti Nagar, Delhi – 110007, India |
|
Mobile No.: |
91-9811158356 |
|
Income-tax
PAN of auditor or auditor's firm : |
AAAPB2797D |
|
|
|
|
Memberships : |
-- |
|
|
|
|
Collaborators : |
-- |
|
|
|
|
Associates/Subsidiaries : |
· Narang Chemist · A N Enterprises |
CAPITAL STRUCTURE
AS ON 31.03.2014
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
250,000 |
Equity Shares |
Rs. 10/- each |
Rs. 2.500 Million |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
250,000 |
Equity Shares |
Rs. 10/- each |
Rs. 2.500 Million |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in Rupees Million]
ABRIDGED BALANCE
SHEET
|
SOURCES OF
FUNDS |
|
|
31.03.2015 [Provisional] |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
|
|
2.500 |
|
|
2] Share Application Money |
|
|
0.000 |
|
|
3] Reserves & Surplus |
|
|
0.527 |
|
|
4] (Accumulated Losses) |
|
|
0.000 |
|
|
NETWORTH |
|
|
3.027 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
|
|
3.136 |
|
|
2] Unsecured Loans |
|
|
2.625 |
|
|
TOTAL BORROWING |
|
|
5.761 |
|
|
DEFERRED TAX LIABILITIES |
|
|
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
|
|
8.788 |
|
|
|
|
|
|
|
|
APPLICATION OF
FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
|
|
0.960 |
|
|
Capital work-in-progress |
|
|
0.000 |
|
|
|
|
|
|
|
|
INVESTMENT |
|
|
0.000 |
|
|
DEFERRED TAX ASSETS |
|
|
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
|
|
18.400 |
|
|
Sundry Debtors |
|
|
24.880 |
|
|
Cash & Bank Balances |
|
|
0.694 |
|
|
Other Current Assets |
|
|
0.000 |
|
|
Loans & Advances |
|
|
0.425 |
|
Total
Current Assets |
|
|
44.399 |
|
|
Less : CURRENT LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Sundry Creditors |
|
|
36.021 |
|
|
Other Current Liabilities |
|
|
0.550 |
|
|
Provisions |
|
|
0.000 |
|
Total
Current Liabilities |
|
|
36.571 |
|
|
Net Current Assets |
|
|
7.828 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
|
|
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
|
|
8.788 |
|
|
SOURCES OF
FUNDS |
|
31.03.2014 |
31.03.2013 |
|
I.
EQUITY AND LIABILITIES |
|
|
|
|
(1)Shareholders' Funds |
|
|
|
|
(a) Share Capital |
|
2.500 |
2.500 |
|
(b) Reserves & Surplus |
|
0.271 |
0.129 |
|
(c) Money received against share warrants |
|
0.000 |
0.000 |
|
|
|
|
|
|
(2) Share
Application money pending allotment |
|
0.000 |
0.000 |
|
Total
Shareholders’ Funds (1) + (2) |
|
2.771 |
2.629 |
|
|
|
|
|
|
(3)
Non-Current Liabilities |
|
|
|
|
(a) Long-term borrowings |
|
1.270 |
0.884 |
|
(b) Deferred tax liabilities (Net) |
|
0.000 |
0.007 |
|
(c)
Other long term liabilities |
|
0.000 |
0.000 |
|
(d)
long-term provisions |
|
0.000 |
0.000 |
|
Total
Non-current Liabilities (3) |
|
1.270 |
0.891 |
|
|
|
|
|
|
(4) Current Liabilities |
|
|
|
|
(a)
Short term borrowings |
|
9.391 |
0.569 |
|
(b)
Trade payables |
|
38.008 |
38.154 |
|
(c)
Other current liabilities |
|
0.090 |
0.406 |
|
(d)
Short-term provisions |
|
0.111 |
0.065 |
|
Total
Current Liabilities (4) |
|
47.600 |
39.194 |
|
|
|
|
|
|
TOTAL |
|
51.641 |
42.714 |
|
|
|
|
|
|
II.
ASSETS |
|
|
|
|
(1) Non-current assets |
|
|
|
|
(a)
Fixed Assets |
|
|
|
|
(i)
Tangible assets |
|
1.133 |
1.426 |
|
(ii)
Intangible Assets |
|
0.000 |
0.000 |
|
(iii)
Capital work-in-progress |
|
0.000 |
0.000 |
|
(iv) Intangible assets under development |
|
0.000 |
0.000 |
|
(b) Non-current
Investments |
|
0.028 |
0.000 |
|
(c) Deferred tax assets
(net) |
|
0.000 |
0.000 |
|
(d) Long-term Loan
and Advances |
|
0.000 |
0.000 |
|
(e)
Other Non-current assets |
|
0.000 |
0.000 |
|
Total
Non-Current Assets |
|
1.161 |
1.426 |
|
|
|
|
|
|
(2) Current assets |
|
|
|
|
(a)
Current investments |
|
1.064 |
6.000 |
|
(b)
Inventories |
|
19.406 |
11.861 |
|
(c)
Trade receivables |
|
29.924 |
21.658 |
|
(d)
Cash and cash equivalents |
|
0.002 |
1.629 |
|
(e)
Short-term loans and advances |
|
0.037 |
0.000 |
|
(f)
Other current assets |
|
0.047 |
0.140 |
|
Total
Current Assets |
|
50.480 |
41.288 |
|
|
|
|
|
|
TOTAL |
|
51.641 |
42.714 |
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
|
|
31.03.2015 [Provisional] |
|
|
|
SALES |
|
|
|
|
|
|
|
Sales |
|
|
262.104 |
|
|
|
Other Income |
|
|
0.020 |
|
|
|
TOTAL |
|
|
262.124 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
Cost of Goods sold |
|
|
252.324 |
|
|
|
Personnel Expenses |
|
|
4.495 |
|
|
|
Administrative Expenses |
|
|
2.230 |
|
|
|
Selling Expenses |
|
|
1.671 |
|
|
|
TOTAL |
|
|
260.720 |
|
|
|
|
|
|
|
|
|
PROFIT
BEFORE INTEREST, DEPRECIATION AND AMORTISATION |
|
|
1.404 |
|
|
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES |
|
|
0.879 |
|
|
|
|
|
|
|
|
|
|
PROFIT
BEFORE DEPRECIATION AND AMORTISATION |
|
|
0.525 |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION |
|
|
0.269 |
|
|
|
|
|
|
|
|
|
|
NET PROFIT |
|
|
0.256 |
|
|
|
PARTICULARS |
|
31.03.2014 |
31.03.2013 |
|
|
|
SALES |
|
|
|
|
|
|
|
Revenue from Operations |
|
287.719 |
161.097 |
|
|
|
Other Income |
|
0.518 |
0.000 |
|
|
|
TOTAL (A) |
|
288.237 |
161.097 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
Purchases of Stock-in-Trade |
|
285.070 |
164.848 |
|
|
|
Changes in inventories of finished goods, work-in-progress
and Stock-in-Trade |
|
(7.545) |
(11.861) |
|
|
|
Employees benefits expense |
|
3.734 |
4.702 |
|
|
|
Other expenses |
|
5.612 |
2.773 |
|
|
|
Preliminary expenses w/off |
|
0.022 |
0.022 |
|
|
|
TOTAL (B) |
|
286.893 |
160.484 |
|
|
|
|
|
|
|
|
|
PROFIT
BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B) (C) |
|
1.344 |
0.613 |
|
|
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES (D) |
|
0.792 |
0.194 |
|
|
|
|
|
|
|
|
|
|
PROFIT
BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D) (E) |
|
0.552 |
0.419 |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION (F) |
|
0.334 |
0.208 |
|
|
|
|
|
|
|
|
|
|
PROFIT BEFORE
TAX (E-F) (G) |
|
0.218 |
0.211 |
|
|
|
|
|
|
|
|
|
Less |
TAX (H) |
|
0.076 |
0.072 |
|
|
|
|
|
|
|
|
|
|
PROFIT AFTER TAX
(G-H) (I) |
|
0.142 |
0.139 |
|
|
|
|
|
|
|
|
|
|
Earnings Per
Share (Rs.) |
|
0.88 |
0.55 |
|
KEY RATIOS
|
PARTICULARS |
|
31.03.2015 [Provisional] |
31.03.2014 |
31.03.2013 |
|
Net Profit Margin (PAT/Sales) |
(%) |
0.10
|
0.05 |
0.09 |
|
|
|
|
|
|
|
Operating Profit Margin (PBDIT/Sales) |
(%) |
0.54
|
0.47 |
0.38 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
0.56
|
0.42 |
0.49 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.08
|
0.08 |
0.08 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Debt/Networth) |
|
1.90
|
3.85 |
0.55 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
1.21
|
1.06 |
1.05 |
FINANCIAL ANALYSIS
[all figures are
in Rupees Million]
YEAR-ON-YEAR GROWTH
|
Year on Year Growth |
31.03.2013 |
31.03.2014 |
31.03.2015
[Provisional] |
|
|
(Rs.
In Million) |
(Rs.
In Million) |
(Rs.
In Million) |
|
Sales |
161.097 |
287.719 |
262.104 |
|
|
|
78.600 |
(8.903) |
%2004-May-2015_files/image011.gif)
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check List by Info Agents |
Available in
Report (Yes / No) |
|
1] |
Year of Establishment |
Yes |
|
2] |
Locality of the firm |
Yes |
|
3] |
Constitutions of the firm |
Yes |
|
4] |
Premises details |
Yes |
|
5] |
Type of Business |
Yes |
|
6] |
Line of Business |
Yes |
|
7] |
Promoter's background |
Yes |
|
8] |
No. of employees |
Yes |
|
9] |
Name of person contacted |
Yes |
|
10] |
Designation of contact
person |
Yes |
|
11] |
Turnover of firm for last
three years |
Yes |
|
12] |
Profitability for last
three years |
Yes |
|
13] |
Reasons for variation
<> 20% |
-- |
|
14] |
Estimation for coming
financial year |
Yes |
|
15] |
Capital in the business |
Yes |
|
16] |
Details of sister
concerns |
Yes |
|
17] |
Major suppliers |
Yes |
|
18] |
Major customers |
Yes |
|
19] |
Payments terms |
Yes |
|
20] |
Export / Import details
(if applicable) |
No |
|
21] |
Market information |
-- |
|
22] |
Litigations that the firm
/ promoter involved in |
-- |
|
23] |
Banking Details |
Yes |
|
24] |
Banking facility details |
Yes |
|
25] |
Conduct of the banking
account |
Yes |
|
26] |
Buyer visit details |
-- |
|
27] |
Financials, if provided |
Yes |
|
28] |
Incorporation details, if
applicable |
Yes |
|
29] |
Last accounts filed at
ROC |
Yes |
|
30] |
Major Shareholders, if
available |
Yes |
|
31] |
Date of Birth of
Proprietor/Partner/Director, if available |
Yes |
|
32] |
PAN of
Proprietor/Partner/Director, if available |
Yes |
|
33] |
Voter ID No of
Proprietor/Partner/Director, if available |
No |
|
34] |
External Agency Rating,
if available |
No |
------------------------------------------------------------------------------------------------------------------------------
UNSECURED LOANS
(RS.
IN MILLION)
|
PARTICULARS |
31.03.2015 [Provisional] |
|
|
|
|
From Directors |
2.625 |
|
|
|
|
Total |
2.625 |
------------------------------------------------------------------------------------------------------------------------------
NARANG BIOTEC PRIVATE
LIMITED
COMPUTATION OF TOTAL
INCOME
(RS.
IN MILLION)
|
PARTICULARS |
31.03.2014 |
||
|
|
|
|
|
|
Income from
Business or Profession [Chapter IV D] |
|
|
0.330 |
|
|
|
|
|
|
NARANG BIOTEC PRIVATE LIMITED |
|
|
|
|
Profit as per Profit and Loss Account |
|
0.218 |
|
|
|
|
|
|
|
Add: Depreciation debited in Profit and Loss Account |
|
0.334 |
|
|
|
|
------------ |
|
|
Total |
|
0.552 |
|
|
|
|
|
|
|
Less: Depreciation as per Chart u/s 32 |
0.221 |
0.221 |
|
|
|
|
------------ |
|
|
|
|
0.330 |
|
|
|
|
|
------------ |
|
Gross Total
Income |
|
|
0.330 |
|
|
|
|
------------ |
|
Total Income |
|
|
0.330 |
|
Round off u/s 288A |
|
|
0.330 |
|
|
|
|
------------ |
|
|
|
|
|
|
Calculation of
Mat |
|
|
0.218 |
|
|
|
|
|
|
Profit as per Part II and III of Schedule VI |
|
0.142 |
|
|
|
|
|
|
|
Add: Income Tax u/s 40 (a) (ii) |
|
0.076 |
|
|
|
|
------------ |
|
|
Total |
|
0.218 |
|
|
|
|
|
|
|
Tax calculated @ 18.5% on Book Profit is Rs. 0.040 Million |
|
|
|
|
Tax Due |
0.099 |
|
|
|
Educational Cess |
0.003 |
|
|
|
|
------------ |
|
|
|
|
0.102 |
|
|
|
T.D.S. |
0.007 |
|
|
|
|
------------ |
|
|
|
Advance Tax |
0.095 |
|
|
|
|
0.035 |
|
|
|
|
------------ |
|
|
|
|
0.060 |
|
|
|
Interest u/s 234 A/B/C |
0.010 |
|
|
|
|
------------ |
|
|
|
|
0.070 |
|
|
|
Deposit u/s 140A |
0.070 |
|
|
|
|
------------ |
|
|
|
Refundable
[Round off u/s 288B] |
0.000 |
|
|
------------------------------------------------------------------------------------------------------------------------------
NARANG BIOTEC PRIVATE
LIMITED
PROJECTED BALANCE SHEET
(RS.
IN MILLION)
|
SOURCES OF
FUNDS |
|
31.03.2017 |
31.03.2016 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
|
2.500 |
2.500 |
|
|
2] Share Application Money |
|
0.000 |
0.000 |
|
|
3] Reserves & Surplus |
|
2.327 |
1.127 |
|
|
4] (Accumulated Losses) |
|
0.000 |
0.000 |
|
|
NETWORTH |
|
4.827 |
3.627 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
|
14.800 |
15.050 |
|
|
2] Unsecured Loans |
|
4.000 |
3.000 |
|
|
TOTAL BORROWING |
|
18.800 |
18.050 |
|
|
DEFERRED TAX LIABILITIES |
|
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
|
23.627 |
21.677 |
|
|
|
|
|
|
|
|
APPLICATION OF
FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
|
0.700 |
0.600 |
|
|
Capital work-in-progress |
|
0.000 |
0.000 |
|
|
|
|
|
|
|
|
INVESTMENT |
|
0.000 |
0.000 |
|
|
DEFERRED TAX ASSETS |
|
0.000 |
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
|
32.500 |
30.000 |
|
|
Sundry Debtors |
|
23.300 |
21.100 |
|
|
Cash & Bank Balances |
|
0.127 |
0.177 |
|
|
Other Current Assets |
|
0.000 |
0.000 |
|
|
Loans & Advances |
|
0.500 |
0.500 |
|
Total
Current Assets |
|
56.427 |
51.777 |
|
|
Less : CURRENT LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Sundry Creditors |
|
32.500 |
30.000 |
|
|
Other Current Liabilities |
|
1.000 |
0.700 |
|
|
Provisions |
|
0.000 |
0.000 |
|
Total
Current Liabilities |
|
33.500 |
30.700 |
|
|
Net Current Assets |
|
22.927 |
21.077 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
|
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
|
23.627 |
21.677 |
|
------------------------------------------------------------------------------------------------------------------------------
NARANG BIOTEC PRIVATE
LIMITED
PROJECTED PROFIT & LOSS ACCOUNT
(RS.
IN MILLION)
|
|
PARTICULARS |
|
31.03.2017 |
31.03.2016 |
|
|
|
SALES |
|
|
|
|
|
|
|
Sales |
|
400.000 |
330.000 |
|
|
|
Other Income |
|
0.200 |
0.100 |
|
|
|
TOTAL |
|
400.200 |
330.100 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
Cost of Goods sold |
|
385.000 |
317.500 |
|
|
|
Personnel Expenses |
|
6.000 |
5.400 |
|
|
|
Administrative Expenses |
|
3.000 |
2.500 |
|
|
|
Selling Expenses |
|
2.400 |
2.000 |
|
|
|
TOTAL |
|
396.400 |
327.400 |
|
|
|
|
|
|
|
|
|
PROFIT
BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION |
|
3.800 |
2.700 |
|
|
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES |
|
1.800 |
1.600 |
|
|
|
|
|
|
|
|
|
|
PROFIT
BEFORE TAX, DEPRECIATION AND AMORTISATION |
|
2.000 |
1.100 |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION |
|
0.300 |
0.250 |
|
|
|
|
|
|
|
|
|
|
PROFIT BEFORE
TAX |
|
1.700 |
0.850 |
|
|
|
|
|
|
|
|
|
Less |
INCOME TAX |
|
0.500 |
0.250 |
|
|
|
|
|
|
|
|
|
|
PROFIT AFTER TAX
|
|
1.200 |
0.600 |
|
|
|
|
|
|
|
|
|
|
Earnings Per
Share (Rs.) |
|
4.80 |
2.40 |
|
------------------------------------------------------------------------------------------------------------------------------
INDEX OF CHARGES
|
S.NO. |
CHARGE ID |
DATE OF CHARGE CREATION/MODIFICATION |
CHARGE AMOUNT SECURED |
CHARGE HOLDER |
ADDRESS |
SERVICE REQUEST NUMBER (SRN) |
|
1 |
10401656 |
29/12/2012 |
14,800,000.00 |
CORPORATION BANK |
E-28, SUNDER BHAWAN,
KAMLA NAGAR, DELHI, DELHI - |
B67500330 |
CORPORATE
INFORMATION
The Company is engaged in the business of trading of Medicines and
pharma products. The company is having its Head Office at 6943/2, Jaipuria Building,
Kolhapur Road, Kamla Nagar, Delhi – 110007.
FIXED ASSETS:
· Vehicles
· Furniture and Fixture
· Invertor
· Computers
· Office Equipment
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its
beneficial owners, controlling shareholders or senior officers as terrorist or
terrorist organization or whom notice had been received that all financial
transactions involving their assets have been blocked or convicted, found
guilty or against whom a judgement or order had been entered in a proceedings
for violating money-laundering, anti-corruption or bribery or international
economic or anti-terrorism sanction laws or whose assets were seized, blocked,
frozen or ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the
property or assets of the subject are derived from criminal conduct or a
prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction registered
against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No
record exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our
market survey revealed that the amount of compensation sought by the subject is
fair and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on Corporate
Governance to identify management and governance. These factors often have been
predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs. 63.58 |
|
|
1 |
Rs. 97.99 |
|
Euro |
1 |
Rs. 70.53 |
INFORMATION DETAILS
|
Information Gathered
by : |
NYA |
|
|
|
|
Analysis Done by
: |
KAR |
|
|
|
|
Report Prepared
by : |
BVA |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
3 |
|
PAID-UP CAPITAL |
1~10 |
4 |
|
OPERATING SCALE |
1~10 |
3 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
3 |
|
--PROFITABILITY |
1~10 |
2 |
|
--LIQUIDITY |
1~10 |
3 |
|
--LEVERAGE |
1~10 |
3 |
|
--RESERVES |
1~10 |
3 |
|
--CREDIT LINES |
1~10 |
3 |
|
--MARGINS |
-5~5 |
-- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
DEFAULTER |
|
|
|
--RBI |
YES/NO |
NO |
|
--EPF |
YES/NO |
NO |
|
TOTAL |
|
27 |
This score serves as
a reference to assess SC’s credit risk and to set the amount of credit to be extended.
It is calculated from a composite of weighted scores obtained from each of the
major sections of this report. The assessed factors and their relative weights
(as indicated through %) are as follows:
Financial
condition (40%) Ownership background
(20%) Payment record
(10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.